In Pain relief Buflam MTS Tablet relieves pain, reduce swelling and ease inflammation in conditions like rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. It also helps to manage short term symptoms such as back pain, toothache or pain in the ear and throat. It works by reducing substances in the body that cause pain and swelling. Buflam MTS Tablet also reduces fever associated with any painful conditions. This medicine does not cause acidity due to the presence of Magnesium oxide in it.
It is unsafe to consume alcohol with Buflam MTS Tablet.
Buflam MTS Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Buflam MTS Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Buflam MTS Tablet does not usually affect your ability to drive.
Buflam MTS Tablet should be used with caution in patients with kidney disease. Dose adjustment of Buflam MTS Tablet may be needed. Please consult your doctor. Use of Buflam MTS Tablet is not recommended in patients with severe kidney disease. Long term use of this medicine can affect the kidney function.
Buflam MTS Tablet should be used with caution in patients with liver disease. Dose adjustment of Buflam MTS Tablet may be needed. Please consult your doctor. However, the use of Buflam MTS Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Buflam MTS Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More